A
AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
NZX:AFT
Price:
2.9 NZD
-2.36%
Market Closed
Updated:
May 7, 2024
AFT Pharmaceuticals Ltd
Operating Income
|
AFT Pharmaceuticals Ltd
Operating Income Peer Comparison
Comparables:
BLT
CBD
RUA
G
GFI
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Operating Income
NZ$19.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Operating Income
-NZ$1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Cannasouth Ltd
NZX:CBD
|
Operating Income
-NZ$8.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-104%
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Operating Income
-NZ$12m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Operating Income
-NZ$1.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Operating Income?
Operating Income
19.5m
NZD
19.5m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Operating Income amounts to 19.5m NZD.
What is AFT Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
25%
25%
Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for AFT Pharmaceuticals Ltd have been 25% over the past three years .
You don't have any saved screeners yet
